VIATRIS INC (VTRS) Fundamental Analysis & Valuation

NASDAQ:VTRS • US92556V1061

Current stock price

14.81 USD
+0.22 (+1.51%)
At close:
14.8 USD
-0.01 (-0.07%)
Pre-Market:

This VTRS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. VTRS Profitability Analysis

1.1 Basic Checks

  • In the past year VTRS was profitable.
  • In the past year VTRS had a positive cash flow from operations.
  • In multiple years VTRS reported negative net income over the last 5 years.
  • In the past 5 years VTRS always reported a positive cash flow from operatings.
VTRS Yearly Net Income VS EBIT VS OCF VS FCFVTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B

1.2 Ratios

  • The Return On Assets of VTRS (-9.45%) is better than 68.59% of its industry peers.
  • VTRS has a better Return On Equity (-23.89%) than 65.44% of its industry peers.
  • VTRS has a Return On Invested Capital of 3.24%. This is amongst the best in the industry. VTRS outperforms 81.15% of its industry peers.
  • VTRS had an Average Return On Invested Capital over the past 3 years of 3.44%. This is significantly below the industry average of 13.10%.
Industry RankSector Rank
ROA -9.45%
ROE -23.89%
ROIC 3.24%
ROA(3y)-3.62%
ROA(5y)-1.8%
ROE(3y)-9.01%
ROE(5y)-4.67%
ROIC(3y)3.44%
ROIC(5y)3.76%
VTRS Yearly ROA, ROE, ROICVTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20

1.3 Margins

  • The Operating Margin of VTRS (8.63%) is better than 82.20% of its industry peers.
  • In the last couple of years the Operating Margin of VTRS has declined.
  • VTRS has a better Gross Margin (39.55%) than 61.26% of its industry peers.
  • VTRS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.63%
PM (TTM) N/A
GM 39.55%
OM growth 3Y-20.26%
OM growth 5Y-6.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5Y0.79%
VTRS Yearly Profit, Operating, Gross MarginsVTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. VTRS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VTRS is destroying value.
  • VTRS has less shares outstanding than it did 1 year ago.
  • VTRS has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, VTRS has a worse debt to assets ratio.
VTRS Yearly Shares OutstandingVTRS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
VTRS Yearly Total Debt VS Total AssetsVTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • VTRS has an Altman-Z score of 1.03. This is a bad value and indicates that VTRS is not financially healthy and even has some risk of bankruptcy.
  • VTRS's Altman-Z score of 1.03 is in line compared to the rest of the industry. VTRS outperforms 51.31% of its industry peers.
  • VTRS has a debt to FCF ratio of 7.79. This is a slightly negative value and a sign of low solvency as VTRS would need 7.79 years to pay back of all of its debts.
  • The Debt to FCF ratio of VTRS (7.79) is better than 80.10% of its industry peers.
  • A Debt/Equity ratio of 0.85 indicates that VTRS is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.85, VTRS is not doing good in the industry: 74.87% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 7.79
Altman-Z 1.03
ROIC/WACC0.39
WACC8.37%
VTRS Yearly LT Debt VS Equity VS FCFVTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.3 Liquidity

  • A Current Ratio of 1.38 indicates that VTRS should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.38, VTRS is doing worse than 78.01% of the companies in the same industry.
  • VTRS has a Quick Ratio of 1.38. This is a bad value and indicates that VTRS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.82, VTRS is not doing good in the industry: 84.82% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.82
VTRS Yearly Current Assets VS Current LiabilitesVTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. VTRS Growth Analysis

3.1 Past

  • VTRS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.94%.
  • Measured over the past years, VTRS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.71% on average per year.
  • The Revenue has decreased by -2.98% in the past year.
  • Measured over the past years, VTRS shows a small growth in Revenue. The Revenue has been growing by 3.66% on average per year.
EPS 1Y (TTM)-10.94%
EPS 3Y-11.02%
EPS 5Y-11.71%
EPS Q2Q%5.56%
Revenue 1Y (TTM)-2.98%
Revenue growth 3Y-4.2%
Revenue growth 5Y3.66%
Sales Q2Q%4.97%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.43% on average over the next years. This is quite good.
  • Based on estimates for the next years, VTRS will show a small growth in Revenue. The Revenue will grow by 4.23% on average per year.
EPS Next Y5.68%
EPS Next 2Y7.48%
EPS Next 3Y9.98%
EPS Next 5Y16.43%
Revenue Next Year3.64%
Revenue Next 2Y2.8%
Revenue Next 3Y2.73%
Revenue Next 5Y4.23%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
VTRS Yearly Revenue VS EstimatesVTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B
VTRS Yearly EPS VS EstimatesVTRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

8

4. VTRS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 6.28, which indicates a rather cheap valuation of VTRS.
  • Compared to the rest of the industry, the Price/Earnings ratio of VTRS indicates a rather cheap valuation: VTRS is cheaper than 95.81% of the companies listed in the same industry.
  • VTRS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.15.
  • With a Price/Forward Earnings ratio of 5.94, the valuation of VTRS can be described as very cheap.
  • 94.76% of the companies in the same industry are more expensive than VTRS, based on the Price/Forward Earnings ratio.
  • VTRS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.28
Fwd PE 5.94
VTRS Price Earnings VS Forward Price EarningsVTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VTRS indicates a rather cheap valuation: VTRS is cheaper than 92.15% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, VTRS is valued cheaper than 92.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.32
EV/EBITDA 7.47
VTRS Per share dataVTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.1
PEG (5Y)N/A
EPS Next 2Y7.48%
EPS Next 3Y9.98%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. VTRS Dividend Analysis

5.1 Amount

  • VTRS has a Yearly Dividend Yield of 3.25%.
  • Compared to an average industry Dividend Yield of 0.73, VTRS pays a better dividend. On top of this VTRS pays more dividend than 94.76% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, VTRS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.25%

5.2 History

  • VTRS has paid a dividend for at least 10 years, which is a reliable track record.
  • VTRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years4
VTRS Yearly Dividends per shareVTRS Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

5.3 Sustainability

  • VTRS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-15.97%
EPS Next 2Y7.48%
EPS Next 3Y9.98%
VTRS Yearly Income VS Free CF VS DividendVTRS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B

More info and screens

Find the best dividend stocksShow peers with best dividend

VTRS Fundamentals: All Metrics, Ratios and Statistics

VIATRIS INC

NASDAQ:VTRS (4/27/2026, 8:23:06 PM)

Premarket: 14.8 -0.01 (-0.07%)

14.81

+0.22 (+1.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-26
Earnings (Next)05-07
Inst Owners87.28%
Inst Owner Change0.09%
Ins Owners0.4%
Ins Owner Change24.66%
Market Cap17.25B
Revenue(TTM)14.30B
Net Income(TTM)-3.51B
Analysts76.67
Price Target15.83 (6.89%)
Short Float %3.04%
Short Ratio3.43
Dividend
Industry RankSector Rank
Dividend Yield 3.25%
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP-15.97%
Div Incr Years0
Div Non Decr Years4
Ex-Date03-09
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.32%
Min EPS beat(2)4.82%
Max EPS beat(2)5.83%
EPS beat(4)4
Avg EPS beat(4)5.04%
Min EPS beat(4)0.14%
Max EPS beat(4)9.36%
EPS beat(8)5
Avg EPS beat(8)2.36%
EPS beat(12)8
Avg EPS beat(12)2.58%
EPS beat(16)11
Avg EPS beat(16)2.43%
Revenue beat(2)2
Avg Revenue beat(2)2.47%
Min Revenue beat(2)2.14%
Max Revenue beat(2)2.79%
Revenue beat(4)3
Avg Revenue beat(4)1.21%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)2.79%
Revenue beat(8)3
Avg Revenue beat(8)-0.55%
Revenue beat(12)3
Avg Revenue beat(12)-1.29%
Revenue beat(16)3
Avg Revenue beat(16)-1.86%
PT rev (1m)11.71%
PT rev (3m)21.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.63%
EPS NY rev (1m)-0.59%
EPS NY rev (3m)-1.13%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)1.51%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)2.34%
Valuation
Industry RankSector Rank
PE 6.28
Fwd PE 5.94
P/S 1.21
P/FCF 9.32
P/OCF 7.45
P/B 1.17
P/tB N/A
EV/EBITDA 7.47
EPS(TTM)2.36
EY15.94%
EPS(NY)2.49
Fwd EY16.84%
FCF(TTM)1.59
FCFY10.73%
OCF(TTM)1.99
OCFY13.43%
SpS12.28
BVpS12.63
TBVpS-6.14
PEG (NY)1.1
PEG (5Y)N/A
Graham Number25.9011 (74.89%)
Profitability
Industry RankSector Rank
ROA -9.45%
ROE -23.89%
ROCE 4.1%
ROIC 3.24%
ROICexc 3.4%
ROICexgc 14.31%
OM 8.63%
PM (TTM) N/A
GM 39.55%
FCFM 12.94%
ROA(3y)-3.62%
ROA(5y)-1.8%
ROE(3y)-9.01%
ROE(5y)-4.67%
ROIC(3y)3.44%
ROIC(5y)3.76%
ROICexc(3y)3.56%
ROICexc(5y)3.87%
ROICexgc(3y)14.45%
ROICexgc(5y)17.87%
ROCE(3y)4.36%
ROCE(5y)4.79%
ROICexgc growth 3Y-16.47%
ROICexgc growth 5Y2.48%
ROICexc growth 3Y-13.28%
ROICexc growth 5Y8.52%
OM growth 3Y-20.26%
OM growth 5Y-6.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5Y0.79%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 7.79
Debt/EBITDA 3.1
Cap/Depr 16.62%
Cap/Sales 3.25%
Interest Coverage 2.5
Cash Conversion 57.44%
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 0.82
Altman-Z 1.03
F-Score5
WACC8.37%
ROIC/WACC0.39
Cap/Depr(3y)15.31%
Cap/Depr(5y)14.37%
Cap/Sales(3y)2.89%
Cap/Sales(5y)2.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.94%
EPS 3Y-11.02%
EPS 5Y-11.71%
EPS Q2Q%5.56%
EPS Next Y5.68%
EPS Next 2Y7.48%
EPS Next 3Y9.98%
EPS Next 5Y16.43%
Revenue 1Y (TTM)-2.98%
Revenue growth 3Y-4.2%
Revenue growth 5Y3.66%
Sales Q2Q%4.97%
Revenue Next Year3.64%
Revenue Next 2Y2.8%
Revenue Next 3Y2.73%
Revenue Next 5Y4.23%
EBIT growth 1Y-30.48%
EBIT growth 3Y-23.6%
EBIT growth 5Y-3.35%
EBIT Next Year15.31%
EBIT Next 3Y9.11%
EBIT Next 5Y7.08%
FCF growth 1Y-5.38%
FCF growth 3Y-9.65%
FCF growth 5Y27.44%
OCF growth 1Y0.56%
OCF growth 3Y-7.78%
OCF growth 5Y13.46%

VIATRIS INC / VTRS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of VIATRIS INC (VTRS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to VTRS.


What is the valuation status for VTRS stock?

ChartMill assigns a valuation rating of 8 / 10 to VIATRIS INC (VTRS). This can be considered as Undervalued.


How profitable is VIATRIS INC (VTRS) stock?

VIATRIS INC (VTRS) has a profitability rating of 5 / 10.


What is the financial health of VIATRIS INC (VTRS) stock?

The financial health rating of VIATRIS INC (VTRS) is 3 / 10.


Is the dividend of VIATRIS INC sustainable?

The dividend rating of VIATRIS INC (VTRS) is 5 / 10 and the dividend payout ratio is -15.97%.